Epigenomics AG (0QXH)

Currency in EUR
0.89
0.00(0.00%)
Closed·
0QXH Scorecard
Full Analysis
Analysts do not anticipate the company will be profitable this year
Earnings results expected today
Trading near 52-week Low
0QXH is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.890.89
52 wk Range
0.891.50
Key Statistics
Prev. Close
-
Open
0.89
Day's Range
0.89-0.89
52 wk Range
0.89-1.5
Volume
-
Average Volume (3m)
1
1-Year Change
-1.11%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
0QXH Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Niche player in the %INDUSTRY% industry

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Epigenomics AG Company Profile

Epigenomics AG does not have significant operations. Previously, it was involved in liquid biopsy for the early detection of cancer. The company was founded in 1998 and is based in Heidelberg, Germany.

Compare 0QXH to Peers and Sector

Metrics to compare
0QXH
Peers
Sector
Relationship
P/E Ratio
−0.3x−3.5x−0.5x
PEG Ratio
0.000.010.00
Price/Book
-1.6x2.6x
Price / LTM Sales
195.1x8.0x3.3x
Upside (Analyst Target)
-116.7%42.8%
Fair Value Upside
Unlock7.5%6.5%Unlock

Earnings

Latest Release
May 30, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

0QXH Income Statement

FAQ

What Stock Exchange Does Epigenomics AG Trade On?

Epigenomics AG is listed and trades on the London Stock Exchange stock exchange.

What Is the Stock Symbol for Epigenomics AG?

The stock symbol for Epigenomics AG is "0QXH."

What Is the Epigenomics AG Market Cap?

As of today, Epigenomics AG market cap is 780.48K.

What Is Epigenomics AG's Earnings Per Share (TTM)?

The Epigenomics AG EPS (TTM) is -3.15.

When Is the Next Epigenomics AG Earnings Date?

Epigenomics AG will release its next earnings report on 05 Aug 2025.

From a Technical Analysis Perspective, Is 0QXH a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Epigenomics AG Stock Split?

Epigenomics AG has split 0 times.

How Many Employees Does Epigenomics AG Have?

Epigenomics AG has 3 employees.

What is the current trading status of Epigenomics AG (0QXH)?

As of 06 Aug 2025, Epigenomics AG (0QXH) is trading at a price of 0.89, with a previous close of 0.00. The stock has fluctuated within a day range of 0.89 to 0.89, while its 52-week range spans from 0.89 to 1.50.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.